1-6 of 6
María Jesús Peñarrubia, MD
Close
Save search
Sort by
Journal Articles

Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP

Free
Tomás José González-López, MD, Blanca Sánchez-González, MD, Cristina Pascual, MD, María Teresa Alvarez-Roman, MD, Gloria Pérez-Rus, MD, Fernando Fernández-Fuentes, MD, Silvia Bernat, MD, José Angel Hernández-Rivas, MD, Montserrat Cortés, MD, Marcio Andrade, MD, Pavel Olivera, MD, Isidro Jarque, Susana Pérez-Crespo, MD, Marta Gómez-Nuñez, MD, Angeles Fernández-Rodríguez, MD, Violeta Martínez-Robles, MD, Carmen Fernández-Miñano, MD, Miguel Angel Fuertes-Palacio, MD, Abelardo Bárez, MD, Rosa Fisac, MD, Carlos Aguilar, MD, María Jesús Peñarrubia, MD, Erik de Cabo, MD, Eva Mingot, MD, Raquel Ranedo-Zaldo, Esther Arrieta-Cerdán, MD, Miguel A. Sanz, MD PhD, Javier García-Frade, MD, José Ramón González-Porras, MD
Journal: Blood
Blood (2015) 126 (23): 4657.
https://doi.org/10.1182/blood.V126.23.4657.4657
Published: 2015
Journal Articles

Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice

Free
Tomás José González-López, MD, María Teresa Alvarez-Roman, MD, Cristina Pascual, MD, Blanca Sánchez-González, MD, Fernando Fernández-Fuentes, MD, Gloria Pérez-Rus, MD, José Angel Hernández-Rivas, MD, Silvia Bernat, MD, Montserrat Cortés, MD, José María Bastida, MD, Violeta Martínez-Robles, MD, Angeles Fernández-Rodríguez, MD, Pavel Olivera, MD, Estefanía Bolaños, MD, Rafael Alonso, MD, Laura Entrena, MD, Marta Gómez-Nuñez, MD, Nuria Bermejo, MD, María Paz Martínez-Badas, María Jesús Peñarrubia, MD, Arancha Alonso, MD, Inmaculada Soto, MD, María Yera Cobo, MD, Alberto Casaus, MD, Isabel Caparrós, MD, María Perera, MD, Reyes Jiménez Bárcenas, MD, Cecilia Heras, MD, María Calbacho, MD, Maria Tenorio, MD, Armando Luaña, MD, Elsa Lopez-Ansoar, MD, Gerardo Hermida, MD, Javier García-Frade, MD, José Ramón González-Porras, MD, Miguel A. Sanz, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2263.
https://doi.org/10.1182/blood.V126.23.2263.2263
Published: 2015
Journal Articles

Prognostic Factors and Treatment Results in Elderly Patients with Aggressive B-Cell Lymphoma: A Geltamo Observational Study

Free
Emilia Pardal, MD PhD, Eva Diez-Baeza, PhD, Eva González-Barca, MD PhD, Tomas Garcia-Cerecedo, MD PhD, Encarna Monzo, MD PhD, Juan-Manuel Sancho, Jose Maria Moraleda, MDPhD, Raul Cordoba, MD PhD, Fatima De la Cruz, MD PhD, JA Queizan, MD PhD, Maria Rodriguez-Salazar, MD PhD, JA Hernández-Rivas, MD PhD, Belen Navarro, MD PhD, Rosana Diez-Angulo, MD PhD, Maria Cruz Viguria, MD PhD, Maria Vahi, MD PhD, Maria Jesús Peñarrubia, MD PhD, Monica Sanchez, PhD, Miguel Canales, MD PhD, Tomas Gonzalez, MD, Sara Alonso, MD, Maria Dolores Caballero, MD PhD, Alejandro Martin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1508.
https://doi.org/10.1182/blood.V126.23.1508.1508
Published: 2015
Journal Articles

Clinical Impact of CD8+ Cells in Hodgkin Lymphoma Lymphadenopaties. Contribution of Flow Cytometry

Free
Sara Alonso, MD, Maria Belen Vidriales, MD PhD, Maria Dolores Caballero, MD PhD, Oscar Blanco, J Galende, Maria Jesús Peñarrubia, MD PhD, Esther Zato, Abelardo Barez, Julio Davila, Juan Carlos Caballero, MD, Alberto Orfao, MD PhD, Marcos González, MD PhD, Ramon Garcia-Sanz, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1442.
https://doi.org/10.1182/blood.V126.23.1442.1442
Published: 2015
Journal Articles

Development of a High-Throughput Screening Assay with Nurse-like Cell-Based Microenviroment in Chronic Lymphoid Leukemia Cells.

Free
Daniel Primo, PhD, Javier De la Serna, MD PhD, Joaquin Martinez, MD, Marcos González, MD, Javier Lopez, Abelardo Bárez, Macarena Ortiz, MD, Javier Loscertales, MD, Julian Vidán, MD, Alicia Rodriguez, MD, Marta Polo, MD, Sandra Irhaeta, MD, Jose Maria Alonso, MD, Jose Antonio Queizan, MD, Jose Angel Hernandez Rivas, MD, María Jesus Peñarrubia, MD, Julian Gorrochategui, Ana Belen Espinosa, PhD, Elena Arroyo, Melanie Oates, PhD, Andrew R Pettit, FRCP, PhD, Joan Ballesteros, PhD, Pilar Hernandez, PhD
Journal: Blood
Blood (2014) 124 (21): 3639.
https://doi.org/10.1182/blood.V124.21.3639.3639
Published: 2014
Journal Articles

Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

Free
Joan Blade, MD, Laura Rosinol, MD, Juan Jose Lahuerta, MD, Anna Sureda, MD, Javier de la Rubia, MD, Jose Garcia-Larana, MD, Miguel Hernandez-Garcia, MD, Belen Hernandez-Ruiz, MD, Jose Antonio Perez-Simon, MD, Jose Luis Bello, MD, Dolores Carrera, MD, Maria Jesus Penarrubia, MD, Eugenia Abella, MD, Angel Leon, MD, Concepcion Poderos, MD, Juan Carlos Garcia-Ruiz, MD, Joan Besalduch, MD, Rafael Martinez-Martinez, MD, Isabel Perez-Fernandez, MD, Paz Ribas, MD, Jesus San Miguel, MD
Journal: Blood
Blood (2007) 110 (11): 729.
https://doi.org/10.1182/blood.V110.11.729.729
Published: 2007